These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 996201)
1. Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment. Wiles DH; Kolakowska T; McNeilly AS; Mandelbrote BM; Gelder MG Psychol Med; 1976 Aug; 6(3):407-15. PubMed ID: 996201 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of plasma drug and prolactin levels during acute chlorpromazine treatment: a replication study. Kolakowska T; Orr M; Gelder M; Heggie M; Wiles D; Franklin M Br J Psychiatry; 1979 Oct; 135():352-9. PubMed ID: 519119 [TBL] [Abstract][Full Text] [Related]
3. Correlation between plasma levels of prolactin and chlorpromazine in psychiatric patients. Kolakowska T; Wiles DH; McNeilly AS; Gelder MG Psychol Med; 1975 May; 5(2):214-6. PubMed ID: 240179 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment. Kolakowska T; Wiles DH; Gelder MG; McNeilly AS Psychopharmacology (Berl); 1976 Aug; 49(1):101-7. PubMed ID: 8814 [TBL] [Abstract][Full Text] [Related]
5. Correlation between plasma chlorpromazine and its metabolites and clinical ratings in patients with acute relapse of schizophrenic and paranoid psychosis. Phillipson OT; McKeown JM; Baker J; Healey AF Br J Psychiatry; 1977 Aug; 131():172-84. PubMed ID: 912219 [TBL] [Abstract][Full Text] [Related]
6. Effect of chlorpromazine treatment on prolactin levels in cerebrospinal fluid and plasma of psychotic patients. Wode-Helgodt B; Eneroth P; Fyrö B; Gullberg B; Sedvall G Acta Psychiatr Scand; 1977 Oct; 56(4):280-93. PubMed ID: 335789 [TBL] [Abstract][Full Text] [Related]
7. Effect of intramuscular chlorpromazine on serum prolactin levels in schizophrenic patients and normal controls. Meltzer HY; Busch DA; Creese IR; Snyder SH; Fang VS Psychiatry Res; 1981 Aug; 5(1):95-105. PubMed ID: 6944710 [TBL] [Abstract][Full Text] [Related]
8. Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine. Alfredsson G; Bjerkenstedt L; Edman G; Härnryd C; Oxenstierna G; Sedvall G; Wiesel FA Acta Psychiatr Scand Suppl; 1984; 311():49-74. PubMed ID: 6199949 [TBL] [Abstract][Full Text] [Related]
9. Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels. Rivera-Calimlim L; Nasrallah H; Strauss J; Lasagna L Am J Psychiatry; 1976 Jun; 133(6):646-52. PubMed ID: 5901 [TBL] [Abstract][Full Text] [Related]
10. Drug-related and illness-related factors in the outcome of chlorpromazine treatment: testing a model. Kolakowska T; Gelder MG; Orr MW Psychol Med; 1980 May; 10(2):335-43. PubMed ID: 7384333 [TBL] [Abstract][Full Text] [Related]
11. Problems in therapeutic blood monitoring of chlorpromazine. Rivera-Calimlim L Ther Drug Monit; 1982; 4(1):41-9. PubMed ID: 7041337 [TBL] [Abstract][Full Text] [Related]
12. Plasma chlorpromazine concentrations in children with behavioral disorders and mental illness. Rivera-Calimlim L; Griesbach PH; Perlmutter R Clin Pharmacol Ther; 1979 Jul; 26(1):114-21. PubMed ID: 445954 [TBL] [Abstract][Full Text] [Related]
13. Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response. Meltzer HY; Busch DA; Fang VS Psychiatry Res; 1983 Aug; 9(4):271-83. PubMed ID: 6580660 [TBL] [Abstract][Full Text] [Related]
14. Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation. Saletu B; Barbanoj MJ; Anderer P; Sieghart W; Grünberger J Methods Find Exp Clin Pharmacol; 1993 Jun; 15(5):291-312. PubMed ID: 8412414 [TBL] [Abstract][Full Text] [Related]
15. Concentrations of chlorpromazine and two of its active metabolites in plasma and cerebrospinal fluid of psychotic patients treated with fixed drug doses. Wode-Helgodt B; Alfredsson G Psychopharmacology (Berl); 1981; 73(1):55-62. PubMed ID: 6785790 [TBL] [Abstract][Full Text] [Related]
16. Dehalogenation and N-dealkylation of chlorpromazine as revealed by plasma concentrations of metabolites in a population of chronically medicated schizophrenics. Valoti M; Palmi M; Della Corte L; Nardini M; Corti P; Sgaragli GP Methods Find Exp Clin Pharmacol; 1992; 14(6):445-50. PubMed ID: 1469953 [TBL] [Abstract][Full Text] [Related]
18. Promazine. A major plasma metabolite of chlorpromazine in a population of chronic schizophrenics. Sgaragli G; Ninci R; Della Corte L; Valoti M; Nardini M; Andreoli V; Moneti G Drug Metab Dispos; 1986; 14(2):263-6. PubMed ID: 2870904 [TBL] [Abstract][Full Text] [Related]
19. Daytime variation in serum prolactin level in patients receiving oral and depot antipsychotic medication. Goode DJ; Meltzer HY; Fang VS Biol Psychiatry; 1981 Jul; 16(7):653-62. PubMed ID: 7196775 [TBL] [Abstract][Full Text] [Related]
20. The response of prolactin to chlorpromazine stimulation in men with hypogonadotrophic hypogonadism and early pubertal boys: relationship to sex steroid exposure. Winters SJ; Johnsonbaugh RE; Sherins RJ Clin Endocrinol (Oxf); 1982 Apr; 16(4):321-30. PubMed ID: 6807580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]